Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus

Wolfgang Fischl1, Sigrid Elshuber, Sabrina Schrauf

  • 1Clinical Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria.

Journal of Virology
|June 20, 2008
PubMed

Insights

Flavivirus infectivity relies on M protein cleavage. Researchers engineered a tick-borne encephalitis virus (TBEV) mutant activated by chymotrypsin, a protease not usually involved, demonstrating potential for creating on-demand activated viral vectors.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Flavivirus infectivity is critically dependent on the proteolytic cleavage of the precursor M protein (prM) by cellular furin proteases.
  • This cleavage typically occurs at multibasic motifs (R-X-R/K-R), activating the virus.
  • Previous work showed a tick-borne encephalitis virus (TBEV) mutant with an altered motif (R-X-R) could be activated by trypsin.

Purpose of the Study:

  • To adapt a TBEV mutant to chymotrypsin, a protease with different substrate specificity.
  • To investigate the genetic basis and biological consequences of altered protease specificity in flaviviruses.
  • To explore the potential for creating engineered flaviviruses with conditional activation and reduced virulence.

Main Methods:

  • Selection pressure in cell culture to isolate TBEV mutants with chymotrypsin-dependent phenotypes.
  • Site-directed mutagenesis to confirm the role of identified mutations (Ser85Phe, Arg89His) in chymotrypsin activation.
  • Analysis of prM cleavage, virus export kinetics, genotypic stability, and neurovirulence in suckling mice.

Main Results:

  • Two mutations (Ser85Phe and Arg89His) were identified, conferring chymotrypsin-dependent activation of TBEV.
  • These mutations allowed efficient prM cleavage and virus activation by chymotrypsin, despite unusual cleavage site characteristics.
  • Chymotrypsin-dependent TBEV mutants showed reduced neurovirulence in mice compared to wild-type or trypsin-dependent viruses.

Conclusions:

  • Flaviviruses can be engineered to utilize heterologous proteases like chymotrypsin for activation, altering their protease specificity.
  • This approach yields genetically stable viral mutants with unimpaired export kinetics.
  • The generation of virulence-attenuated flaviviruses with on-demand activation is feasible, suggesting applications in creating novel viral vectors or attenuated vaccine candidates.